S Mănescu

Efficacy and Safety of Masitinib in Progressive Forms of Multiple Sclerosis

Patrick Vermersch, Luís Brieva, Robert J. Fox, Friedemann Paul et autres

BACKGROUND AND OBJECTIVES: Masitinib is a selective tyrosine kinase inhibitor, targeting innate immune cells (mast cells and microglia) that are involved in the pathophysiology of progressive multiple sclerosis (MS). Study AB07002 assessed oral masitinib in patients with progressive MS who were progressing …

fr, es, pl, de (code pays fourni par la source)

Primary prevention of cancer. Achievements and perspectives.

S Mănescu

[Aspects of integral anti-tuberculosis chemotherapy in 15 rural medical stations of the Constanţa district].

C Didilescu, P Panghea, N Pavlidi, S Mănescu et autres

The study of aspects of integration of chemotherapy during the initial stages of the anti-tuberculous treatment, carried out in 15 rural medical circumscriptions in the Constantza and mpedgidia anti-tuberculous dispensaries, has demonstrated the applicability of standardized chemotherapy schemes at the level of …